Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern
Saved in:
| Main Authors: | Lei Yue, Jian Zhou, Yanan Zhou, Xiaolei Yang, Tianhong Xie, Mengli Yang, Hongling Zhao, Yuan Zhao, Ting Yang, Hua Li, Hong Xiang, Jie Wang, Shuaiyao Lu, Hongqi Liu, Hong Zhao, Xingchen Wei, Yuhao Zhang, Zhongping Xie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-01-01
|
| Series: | Emerging Microbes and Infections |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2021.1996210 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge
by: Xiangchuan He, et al.
Published: (2021-01-01) -
A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
by: Kwang Su Kim, et al.
Published: (2021-03-01) -
Origins of SARS-CoV-2: Focusing on Science
by: Zheng-Li Shi, et al.
Published: (2021-04-01) -
Aggravated pneumonia and diabetes in SARS-CoV-2 infected diabetic mice
by: Qing Huang, et al.
Published: (2023-12-01) -
Evaluation of the MAScIR SARS-CoV-2 M Kit 2.0 on the SARS-CoV-2 Infection
by: Amal Zouaki, et al.
Published: (2023-01-01)